The weekly litigation news digest is live. Subscribe now

IP Verse

Light Inhibitors For Asthma, Lung And Airway Inflammation, Respiratory, Interstitial, Pulmonary And Fibrotic Disease Treatment - EP2207597

The patent EP2207597 was granted to Lajolla Institute FOR Allergy And Immunology on Feb 19, 2020. The application was filed on Sep 18, 2008 under application number EP08831796A. The patent is currently recorded with a legal status of "Revoked".

EP2207597

LAJOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
Application Number
EP08831796A
Filing Date
Sep 18, 2008
Status
Revoked
Jun 2, 2023
Publication Date
Feb 19, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
EUROPEAN OPPOSITIONSNov 19, 2020LEONARD -

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONWO2008027338
INTERNATIONAL-SEARCH-REPORTEP1336619
INTERNATIONAL-SEARCH-REPORTWO2004024076
INTERNATIONAL-SEARCH-REPORTWO2006054961
OPPOSITIONEP1336619
OPPOSITIONWO0142463
OPPOSITIONWO0179496
OPPOSITIONWO2008027338

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents